Description: Resistance of Cancer Cells to Ctl-mediated Immunotherapy, Hardcover by Bonavida, Benjamin (EDT); Chouaib, Salem (EDT), ISBN 3319178067, ISBN-13 9783319178066, Like New Used, Free shipping in the US This comprehensive volume explores the latest research on themechanisms of resistance in cancer cells to CTL-mediated immunotherapy.Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order forCTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.
Price: 135.25 USD
Location: Jessup, Maryland
End Time: 2024-10-26T02:22:24.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 14 Days
Refund will be given as: Money Back
Return policy details:
Book Title: Resistance of Cancer Cells to Ctl-mediated Immunotherapy
Number of Pages: Xix, 353 Pages
Publication Name: Resistance of Cancer Cells to Ctl-Mediated Immunotherapy
Language: English
Publisher: Springer International Publishing A&G
Publication Year: 2015
Subject: Microbiology, Oncology, Research
Type: Textbook
Item Weight: 266 Oz
Item Length: 9.3 in
Subject Area: Medical
Author: Benjamin Bonavida
Series: Resistance to Targeted Anti-Cancer Therapeutics Ser.
Item Width: 6.1 in
Format: Hardcover
